Correlates of tobacco use among smokers and recent quitters diagnosed with cancer

Patient Education and Counseling

Volumn 46, Issue 2, 2002, Pages 137-145

  Schnoll, Robert A ^a   Malstrom, Michael ^a   James, Calvin ^a   Rothman, Randi L ^a   Miller, Suzanne M ^a   Ridge, John A ^a   Movsas, Benjamin ^a   Unger, Michael ^a   Langer, Corey ^a   Goldberg, Melvyn ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Cancer patients; Correlates of tobacco use; Readiness to quit; Smoking cessation

Indexed keywords

ADULT; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; COUNSELING; EMOTIONAL STRESS; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SELF CONCEPT; SMOKING CESSATION; SMOKING HABIT;

EID: 0036183648     PISSN: 07383991     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-3991(01)00157-4     Document Type: Article

References (74)

1. Smoking cessation and cancer prevention
2. Smoking and smoking cessation in cancer patients
3. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer
4. Smoking history and survival among lung cancer patients
5. Prognostic effect of tobacco and alcohol use in patients with oral tongue cancer
6. Smoking abstinence and small cell lung cancer survival
7. Tobacco usage in patients with head and neck carcinomas: A follow-up study on habit changes and second primary oral/orophayngeal cancers
8. Head and neck cancer survival and lifestyle change
9. Second cancers following oral and pharyngeal cancers: Role of tobacco and alcohol
10. Second primary cancer following laryngeal cancer with special reference to smoking habits
11. Tobacco and lung cancer
12. Second primary tumors in more than 2-year disease-free survivors of small-cell lung cancer in Japan: The role of smoking cessation
13. Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers
14. Second primary cancers related to smoking and treatment of small-cell lung cancer (Lung Cancer Working Cadre)
15. Pharmacologic aspects of cigarette smoking and nicotine addiction
16. The problem of cigarette smoking in radiotherapy for cancer in the head and neck
17. The quality of voice in patients irradiated for laryngeal carcinoma
18. Smoking and mucosal reactions to radiotherapy
19. Serum cotinine as an objective marker for smoking habit in head and neck malignancy
20. Smoking withdrawal and relapse in head and neck cancer patients
21. Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer
22. Cigarette smoking patterns in patients after treatment of upper aerodigestive tract cancers
23. Factors affecting smoking cessation in patients with head and neck cancer
24. Prognostic factors in patients with resected stage I non-small cell lung cancer
25. Smoking before surgery predicts poor long-term survival in patients with stage I non-small cell lung carcinomas
26. Smoking behavior following diagnosis in patients with stage I non-small cell lung cancer
27. Present and past smoking history and other predisposing factors in 100 lung cancer patients
28. Compliance with physician advice to quit smoking: A review of the literature
29. Insights on how to quit smoking: A survey of patients with lung cancer
30. Changes in smoking associated with hospitalization: Quit rates, predictive variables, and intervention implications
31. Determinants of quitting smoking
32. Smoking cessation among patients with chronic obstructive pulmonary disease (COPD)
33. Smokers who are hospitalized: A window of opportunity for cessation interventions
34. Helping hospitalized smokers quit: New directions for treatment and research
35. Smoking cessation: Recent developments in behavioral and pharmacologic interventions
36. Smoking interventions for patients with cancer: Guidelines for nursing practice
37. Predictors of long-term smoking cessation in head and neck cancer patients
38. The transtheoretical model of health behavior change
39. Coping with stress: Examples from the cancer context
40. Clusters of pre-contemplating smokers defined by the perception of the pros, cons, and self-efficacy
41. Relapse and maintenance issues for smoking cessation
42. Randomized controlled trial of smoking cessation counseling after myocardial infarction
43. The importance of self-efficacy in cardiovascular risk factor change
44. Accuracy of smokers risk perceptions
45. Perceived risks of heart disease and cancer among cigarette smokers
46. Stages of change and decisional balance for 12 problem behaviors
47. Pros and cons of quitting, self-efficacy, and the stages of change in smoking cessation
48. Associations between the stages of change and the pros and cons of smoking in a longitudinal study of Swiss smokers
49. Applying the transtheoretical model to a representative sample of smokers
50. Barriers to cancer screening
51. The asbestos worker who smokes: Adding insult to injury
52. The influence of fatalism on self-reported use of Papanicolaou smears
53. Knowledge, behavior, and fears concerning breast and cervical cancer among older low-income Mexican-American women
54. Fatalism among elderly African Americans: Effects on colorectal cancer screening
55. Expression and smoking cessation: Characteristics of depressed smokers and effects of nicotine replacement
56. Cigarette smoking and major depression
57. Nicotine, negative affect, and depression
58. Predictors of smoking cessation and maintenance
59. Promoting smoking cessation among cancer patients: A behavioral model
60. Interactive versus non-interactive interventions and dose-response relationships for stage matched smoking cessation programs in a managed care setting
61. The Fagerstrom test for nicotine dependence
62. Depression and self-medication with nicotine: The modifying influence of the dopamine D4 receptor gene
63. Investigation of mechanisms linking depressed mood to nicotine dependence
64. Reliability of the Fagerstrom tolerance questionnaire and the Fagerstrom test for nicotine dependence
65. Impact of event scale: A measure of subjective distress
66. Quality of measurement of smoking status by self-report and saliva cotinine among pregnant women
67. National incidence of smoking and misclassification among the US married female population
68. Misclassification rates for current smokers misclassified as non-smokers
69. Nicotine dependence versus smoking prevalence: Comparisons among countries and categories of smokers
70. The effectiveness of a nurse-managed minimal smoking-cessation intervention among hospitalized patients with cancer